AbbVie 2014 Annual Report Download - page 117
Download and view the complete annual report
Please find page 117 of the 2014 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107 -
108 -
109 -
110 -
111 -
112 -
113 -
114 -
115 -
116 -
117 -
118 -
119 -
120 -
121 -
122 -
123 -
124 -
125 -
126 -
127 -
128
-
129
-
130
-
131
-
132
-
133
-
134
-
135
-
136
-
137
-
138
-
139
-
140
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
-
159
-
160
-
161
-
162
-
163
-
164
-
165
-
166
-
167
-
168
-
169
-
170
-
171
-
172
-
173
-
174
-
175
-
176
-
177
-
178
-
179
-
180
-
181
-
182
 |
 |
13NOV201221352027
Exhibit
Number Exhibit Description
10.27 *Form of AbbVie Inc. Performance Restricted Stock Agreement (Interim) (incorporated by
reference to Exhibit 10.6 of the Company’s Quarterly Report on Form 10-Q for the quarterly
period ended March 31, 2013).**
10.28 *Form of AbbVie Inc. Non-Qualified Stock Option Agreement (incorporated by reference to
Exhibit 10.7 of the Company’s Quarterly Report on Form 10-Q for the quarterly period ended
March 31, 2013).**
10.29 *Form of AbbVie Inc. Non-Qualified Replacement Stock Option Agreement (incorporated by
reference to Exhibit 10.8 of the Company’s Quarterly Report on Form 10-Q for the quarterly
period ended March 31, 2013).**
10.30 *Revolving Credit Agreement, dated as of August 18, 2014, among AbbVie, New AbbVie, Foreign
HoldCo, JPMorgan Chase Bank, N.A. and the lenders and other parties party thereto (incorporated
by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K filed on August 21,
2014).
12 Ratio of Earnings to Fixed Charges
21 Subsidiaries of AbbVie Inc.
23.1 Consent of Independent Registered Public Accounting Firm.
23.2 Consent of Independent Registered Public Accounting Firm.
31.1 Certification of Chief Executive Officer Required by Rule 13a-14(a) (17 CFR 240.13a-14(a)).
31.2 Certification of Chief Financial Officer Required by Rule 13a-14(a) (17 CFR 240.13a-14(a)).
32.1 Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002.
32.2 Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002.
101 The following financial statements and notes from the AbbVie Inc. Annual Report on Form 10-K
for the year ended December 31, 2014 filed on February 20, 2015, formatted in XBRL:
(i) Consolidated Statements of Earnings; (ii) Consolidated Statements of Comprehensive Income;
(iii) Consolidated Balance Sheets; (iv) Consolidated Statements of Equity; (v) Consolidated
Statements of Cash Flows; and (vi) the Notes to Consolidated Financial Statements.
The AbbVie Inc. 2015 Proxy Statement will be filed with the Securities and Exchange Commission
under separate cover on or about March 20, 2015.
* Incorporated herein by reference. Commission file number 001-35565.
** Denotes management contract or compensatory plan or arrangement required to be filed as an exhibit
hereto.
AbbVie will furnish copies of any of the above exhibits to a stockholder upon written request to the
Secretary, AbbVie Inc., 1 North Waukegan Road, North Chicago, Illinois 60064.
2014 Form 10-K 111